ArticleAnnals of medicine2026
Factors influencing quality of life in multiple sclerosis patients in Northwest Ethiopia: a multicentre cross-sectional study.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple sclerosis (MS) significantly affects patients' quality of life (QoL), particularly in resource-limited settings. This multicentre study aimed to identify factors influencing QoL among MS patients in Northwest Ethiopia, where data are scarce.
methodsA cross-sectional study was conducted from January to June 2024 among 427 MS patients (≥18 years, diagnosed using McDonald criteria) attending three referral hospitals (University of Gondar, Debre Tabor, Felege Hiwot). Stratified sampling ensured representation across disease severity. Sociodemographic, clinical, psychological and behavioural data were collected. QoL was measured using the MSQOL-54 questionnaire. Multiple regression identified predictors of QoL, expressed as β coefficients and
resultsThe mean age of participants was 43 years, and 58.3% were female. Disease severity was classified as mild in 50.4%, moderate in 34.7%, and severe in 15.0% of participants. Low physical and mental QoL were reported in 34.9% and 31.6%, respectively. Lower QoL was significantly associated with greater disease severity (β = -0.85,
conclusionsQoL among MS patients was strongly influenced by disease severity, treatment adherence (among patients receiving DMT), fatigue, psychological distress, cognitive function, physical activity and social support. Interventions targeting these modifiable factors may improve patient outcomes. This study provides important evidence from Ethiopia and helps address a significant knowledge gap regarding MS care in resource-limited settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.